BIOXYNE LIMITED — Director's Dealing 2017

Dec 10, 2017

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity Bioxyne Limited ABN 97 084 464 193

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Mr Anthony Ho
Date of last notice	5 December 2017

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct & Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	A.P. & C.H. Ho A/C>
Date of change	11 December 2017
No. of securities held prior to change	Direct 17,800,000 fully paid ordinary shares 4,450,000 unlisted options exercisable at $0.01 per share expiry 15 December 2017. Indirect 2,975,000 fully paid ordinary shares 1,500,000 options exercisable at 2.34 cents per share expiry24November 2019
Class	Ordinary Shares
Number acquired	4,450,000
Number disposed	Nil – exercise of options
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	$44,500

• See chapter 19 for defined terms.

Appendix 3Y Page 1

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

No. of securities held after change Direct 22,250,000 fully paid ordinary shares Indirect 2,975,000 fully paid ordinary shares 1,500,000 options exercisable at 2.34 cents per share expiry 24 November 2019 Nature of change Exercise of 4,450,000 options at 1 cent per

Example: on-market trade, off-market trade, exercise of options, issue of share expiry date 15 December 2017 securities under dividend reinvestment plan, participation in buy-back

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract N/A Nature of interest Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed No above traded during a[+] closed period where prior written clearance was required? If so, was prior written clearance provided to allow the N/A trade to proceed during this period? If prior written clearance was provided, on what date N/A was this provided?

• See chapter 19 for defined terms.

Appendix 3Y Page 2

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity Bioxyne Limited ABN 97 084 464 193

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Mr Patrick Ford
Date of last notice	31 October 2017

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	1. Diskdew Pty Ltd 2. P Ford Superannuation Pty Ltd as trustee for the Patrick Ford Super Fund A/C
Date of change	11 December 2017
No. of securities held prior to change	1. 8,800,000 fully paid ordinary shares and 2,075,000 unlisted option exercise price $0.01 with expiry 15 December 2017 2. 10,000,000 fully paid ordinary shares and 2,500,000 unlisted options exercisable at $0.01 per share expiry 15 December 2017 1,250,000 options exercisable at 2.34 cents per sharewith expiry24November 2019
Class	Ordinary shares

• See chapter 19 for defined terms.

Appendix 3Y Page 1

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

Number acquired	1. 2,075,000 ordinary shares 2. 2,500,000 ordinary shares
Number disposed	Nil – options exercised
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	$45,750
No. of securities held after change	1. 10,875,000 fully paid ordinary shares 2. 12,500,000 fully paid ordinary shares 1,250,000 options exercisable at 2.34 cents per share with expiry 24 November 2019
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back	Exercise of 4,575,000 options at 1 cent per share expiry 15 December 2017

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest
Name of registered holder (if issued securities)
Date of change
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed
Interest acquired
Interest disposed

• See chapter 19 for defined terms.

Appendix 3Y Page 2

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required?	No
If so, was prior written clearance provided to allow the trade to proceed during this period?	N/A
If prior written clearance was provided, on what date was this provided?	N/A

• See chapter 19 for defined terms.

Appendix 3Y Page 3

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity Bioxyne Limited ABN 97 084 464 193

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Dr Peter French
Date of last notice	4 August 2017

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.
Date of change	11 December 2017
No. of securities held prior to change	405,210 Ordinary shares 1,000,000 unlisted options exercisable at $0.0234 expiry24November 2019
Class	Ordinary
Number acquired	(1) 1,000,000
Number disposed	(2) 220,000
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	(1) $23,400 (2) $20,683
No. of securities held after change	1,185,210 ordinary shares

• See chapter 19 for defined terms.

Appendix 3Y Page 1

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

Nature of change

Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back

1) Exercise of options 2) On market trade

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

==> picture [434 x 318] intentionally omitted <==

----- Start of picture text -----

Detail of contract N/A
Nature of interest
Name of registered holder
(if issued securities)
Date of change
No. and class of securities to
which interest related prior to
change
Note: Details are only required for a contract in relation
to which the interest has changed
Interest acquired
Interest disposed
Value/Consideration
Note: If consideration is non-cash, provide details and an
estimated valuation
Interest after change
----- End of picture text -----

Part 3 –[+] Closed period

==> picture [434 x 99] intentionally omitted <==

----- Start of picture text -----

Were the interests in the securities or contracts detailed No
above traded during a [+] closed period where prior
written clearance was required?
If so, was prior written clearance provided to allow the N/A
trade to proceed during this period?
If prior written clearance was provided, on what date N/A
was this provided?
----- End of picture text -----

• See chapter 19 for defined terms.

Appendix 3Y Page 2

11/3/2002